Aflatoxin B2a (AFB2a) antiserum has been previously used in an enzyme-linked immunosorbent assay (ELISA) for the quantitation of AFB1 and AFB2a. The present investigation examined the reactivity of the antiserum toward those adducts and metabolites of AFB1 believed to play a major role in aflatoxicosis and carcinogenesis. 2,3-Dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 (AFB1-N7-Gua), the putative 2,3-(N5-formyl-2',5',6'-triamino-4-oxo-N5-pyrimidyl)-3-hydroxyaflatoxin B1 (AFB,-FAPyr), 2,3-dihydro-2,3-dihydroxyaflatoxin B1 (AFB,-diol), AFB1-N7-Gua-modified DNA, and AFB,-FAPyr-modified DNA were prepared by in vitro incubation or chemical methods and subjected to competitive AFB2a ELISA. The antiserum showed significant reactivity with all five compounds, indicating that it had a high degree of specificity for both the cyclopentenone and the methoxy group of the parent aflatoxin molecule. Sensitivity for AFB-N7-Gua-modified DNA, AFB1-FAPyr-modified DNA, and AFB1-diol by the ELISA method was 0.1 pmol per assay. To test the applicability of immunological detection of covalent binding of AFB1 to DNA, the ELISA was compared with a conventional radioisotopic assay in two in vitro studies. The results showed that estimates of the kinetics and substrate dependence of covalent binding to calf thymus DNA in rat microsomal incubation mixtures by both methods were comparable. The broad specificity AFB2a antibody might be of considerable value in the detection of AFB1 macromolecular adducts and related metabolites in epidemiological investigations or in the diagnosis of aflatoxicosis.
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Aflatoxin B1 (AFB,) is a potent, naturally occurring hepatotoxin and hepatocarcinogen produced by the fungal species Aspergillus flavus and A. parasiticus. In view of its capacity for entry into the food supply via grain and nut products and epidemiological studies suggesting a potential role for it in human liver cancer (3, 4) , extensive investigations on the metabolic fate of AFB1 have been conducted (5, 13, 25) . The AFB1 metabolites capable of reacting with cellular macromolecules appear to be of particular significance. The reactions yielding these metabolites are summarized in Fig. 1 . Metabolic activation of AFB1 by a cytochrome P45o to a reactive epoxide at the 2,3 position of the terminal furan and subsequent covalent binding to macromolecular nucleophiles have been suggested to be critical events in the carcinogenic process (24, 33 DNA has revealed the initial major nucleic acid adduct to be 2,3-dihydro-2-(N7-guanyl)-3-hydroxy AFB1 (AFB1-N7-Gua) (9, 20, 23) . AFBI-N7-Gua has been determined to be a major urinary metabolite in rats exposed to AFB1 (2).
In vitro and in vivo kinetic studies have shown that because of a localized positive charge, the imidazole ring of AFB1-N7-Gua-modified DNA can spontaneously open to yield a more stable persistent DNA adduct (8, 35) . The base adduct released after acid hydrolysis of this modified DNA has the putative structure 2,3-dihydro-2,3-(N5-formyl-2' ,5 ',6'-triamino-4-oxo-N5-pyrimidyl)-3-hydroxyaflatoxin B5 (AFB1-FAPyr) (8, 20) . Covalent (19, 26, 27) and after the degradation of AFB1-N7-Gua-modified DNA (35 conditions, the metabolite becomes a dialdehydic phenolate ion which is capable of forming Schiff base adducts with amino groups of cellular proteins. Although early investigations suggested that AFB2a, the hemiacetal of AFB1, was a major reactive metabolite in vitro, Neal et al. (27) recently reported that the suspect metabolite in these cases probably was AFB1-diol, the misidentification apparently arising from the similarity in the UV spectra of the two compounds. Until recently, the metabolism of carcinogens has been studied primarily by the use of radioisotopes and high-performance liquid chromatography (HPLC). In many situations, the expense and instability of radiolabeled carcinogens limit their use in long-term, low-dose feeding studies. The effectiveness of HPLC can be reduced by interference and sensitivity problems. A third means of studying carcinogen metabolism was initiated by Poirier et al. (32) when they quantitated N-2-acetyl aminofluorene adducts by radioimmunoassay (RIA). Since then, formation of these and other carcinogen adducts has been followed by RIA (18) as well as by enzymelinked immunosorbent assay (ELISA) and ultrasensitive enzyme radioimmunoassay (USERIA) (14, 15) .
Two general types of immunogens can be used for the production of carcinogen antibodies. In one approach, carcinogen-modified DNA is complexed electrostatically with methylated bovine serum albumin (BSA) and used for immunization (15) . Alternatively, the carcinogen can be chemically modified and conjugated to a carrier protein such as BSA (32) . Depending on the portion of the hapten molecule exposed distally from the immunogen, the resultant antibody will react in differing degrees with the parent carcinogen, its macromolecular adducts, and related metabolites. Using the first approach, Haugen et al. (11) immunized mice with AFB1-N7-Guamodified DNA and methylated BSA to prepare a highly specific monoclonal antibody that could be used in the USERIA quantitation of AFB1-N7-Gua-modified DNA and AFB1-FAPyr-modified DNA. The monoclonal antibody, however, required DNA for immune recognition and did cross-react with the base adducts or AFB1-diol. Regarding the second approach, several methods for derivatization and conjugation of AFB1 to BSA have been described by our laboratory and others (7, 10, 16, 17) . In one of these methods, AFB2a is converted to its dialdehydic phenolate ion under alkaline conditions and allowed to react with BSA (1, 10). The resultant Schiff base adduct is then reduced to a stable conjugate by the addition of sodium borohydride. Immunoassays have revealed that antibody prepared against the AFB2a-BSA conjugate has the following rank order of crossreactivity with aflatoxin analogs: AFB2a = AFB1 > AFB2 > aflatoxicol > AFMI > AFG1 > AFG2. The cyclopentenone and methoxy groups thus have the immunodominant function in the immunogen. Since AFB1 macromolecular adducts also have unmodified cyclopentenone and methoxy moieties ( Fig. 1 Essigmann et al. (9) . Crude hydrolysates were pumped onto the column with a Glenco HPLC pumping system (Glenco Scientific, Houston, Tex.), and an ISCO model UA-4 absorbance monitor (Instrumentation Specialties Co., Lincoln, Nebr.) was used to follow the stepwise isocratic elution of adducts by methanol-water at 254 nm. Concentrations of the two base adducts were then determined by quantitating 14C present in purified preparations. Estimates of AFB1-N7-Gua made by UV absorbance at 360 nm (20) were found to be identical to those made with radiolabel. The purity of AFB1, AFB2a, AFB,-diol, AFB,-N7-Gua, and AFB1-FAPyr was routinely tested on a Waters analytical HPLC equipped with a ,u Bondapak C18 reversed-phase column. The (20) . Further purification was performed when necessary by repeated analytical HPLC with the same solvent system. AFB1 solutions were handled with polyvinyl gloves in a fume hood. Contaminated glassware was detoxified by soaking in 5% sodium hypochlorite overnight.
Production of AFB21, antiserum. AFB2a was conjugated to fatty acid-free BSA by a reductive alkylation method, and the resultant immunogen was injected into multiple sites of rabbits as previously described (10) . The rabbits were bled via the marginal ear vein at weekly intervals, and the IgG was purified by the method of Herbert et al. (12) . IgG concentration was determined spectrophotometrically (21) , and titers were determined by ELISA (28 
RESULTS
Reactivity of AFB2. antibody. The various AFB1-DNA adducts and related metabolites were prepared chemically or by in vitro incubation in a rat microsomal metabolic activation system, and their molar concentrations were determined by radiolabel or UV spectroscopy. Figure 2A and B indicates the high degree of cross-reactivity of the AFB2a antiserum towards these compounds as determined by a competitive ELISA using AFB2a-peroxidase as the marker ligand. Minimal detection levels for AFB2a, AFB,-diol, AFB1, AFB1-N7-Gua-modi- with BSA (10 mg/ml), human IgG (10 mg/ml), or lysozyme (10 mg/ml) all showed comparable competition patterns to those found for the compounds without the protein preincubation. Since under these incubation conditions, AFB2a and AFB1-diol form Schiff base adducts with proteins (1, 26) , the AFB2a antiserum might also be useful for detecting such adducts.
ELISA of AFBI-DNA adducts formed in vitro.
To Fig. 2A and B, except the data for AFB2, AFG1, AFG2, AFM1, and aflatoxicol, which were taken from our previous study (10) .
VOL. 44, 1982 on January 27, 2018 by guest http://aem.asm.org/ the competitive ELISA described here. Furthermore, the competitive AFB2a ELISA was simpler to perform, was subject to a much lower signal-to-noise ratio than the USERIA, and did not require use of radioisotopes. Depending on the specific investigation being undertaken, therefore, the relative advantages and disadvantages of the broad specificity AFB2a rabbit antibody and the specific monoclonal AFB,-DNA antibody must be considered.
In this report, we have found that AFB2a antibody can cross-react with a number of important aflatoxin metabolites and aflatoxin macromolecular adducts. 
